Davidc Marek News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Davidc marek. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Davidc Marek Today - Breaking & Trending Today

Analysts Set Myovant Sciences Ltd. (NYSE:MYOV) Price Target at $23.40

Shares of Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) have been given an average recommendation of “Hold” by the seven analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have given a buy recommendation to the […] ....

New Zealand General , New Zealand , Davidc Marek , Ferreira Juan Camilo Arjona , Securities Exchange Commission , Zacks Investment Research , Myovant Sciences , Analyst Recommendations For Myovant Sciences , Norges Bank , Wellington Management Group , Bellevue Group , Janus Henderson Group , Myovant Sciences Ltd , Myovant Sciences Get Rating , Get Rating , Investment Research , Exchange Commission , Street Corp , Henderson Group , Management Group , Sciences Ltd , Nyse Myov ,

Myovant Sciences (NYSE:MYOV) Downgraded by Zacks Investment Research

Myovant Sciences (NYSE:MYOV – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women’s health diseases and other endocrine-related disorders, including […] ....

Davidc Marek , Ferreira Juan Camilo Arjona , Zacks Investment Research , Myovant Sciences , Analyst Recommendations For Myovant Sciences , Lazard Asset Management , Myovant Sciences Ltd , Myovant Sciences Company Profile Get Rating , Cornerstone Advisory , Myovant Sciences Inc , Barclays Plc , Macquarie Group Ltd , Get Rating , Forest Capital Management , Asset Management , Sciences Company Profile , Nyse Myov ,

-$0.54 EPS Expected for Myovant Sciences Ltd. (NYSE:MYOV) This Quarter

Equities analysts predict that Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) will announce earnings of ($0.54) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Myovant Sciences’ earnings, with the highest EPS estimate coming in at ($0.40) and the lowest estimate coming in at ($0.63). Myovant […] ....

Davidc Marek , Matthew Lang , Thomson Reuter , Russell Investments Group Ltd , Securities Exchange Commission , Zacks Investment Research , Myovant Sciences , Marshall Wace , Myovant Sciences Ltd , Cubist Systematic Strategies , Myovant Sciences Inc , Dynamic Technology Lab Private Ltd , Myovant Sciences Get Rating , Get Rating , Zacks Investment , Myovant Science , Investment Research , General Counsel Matthew Lang , Exchange Commission , Systematic Strategies , Technology Lab Private Ltd , Investments Group , Nyse Myov ,